STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

Clinical trial NCT06975293 · RECRUITING

Trial details

NCT number: NCT06975293
Sponsor: STORM Therapeutics LTD
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor Sarcoma Leiomyosarcoma Dedifferentiated Liposarcoma

Start date: 2025-05-05
Primary completion: 2027-12-29
Enrollment: 107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.